Table 1.
Control | WIR | ZnSO4 | WIR+ ZnSO4 | WIR+MT | |
CD content in plasma (A/mL) | 10.19±1.81 | 37.37±2.04b | 10.33±2.07a | 19.08±1.52ab | 18.64±1.32ab |
CD content in stomach (A/g tissue) | 39.96±6.74 | 73.09±3.71b | 51.39±4.41ab | 60.48±3.93ab | 62.43±4.99ab |
CD content in liver (A/g tissue) | 64.87±3.05 | 83.26±3.78b | 66.99±4.7a | 68.07±4.93a | 80.76±3.16b |
MDA content in plasma (nmol/mL) | 3.65±0.41 | 4.88±0.30b | 3.98±0.35a | 4.20±0.21a | 4.77±0.18b |
MDA content in stomach (nmol/g tissue) | 4.17±0.18 | 5.06±0.77 | 4.67±0.54 | 4.21±0.62 | 4.01±0.32a |
MDA content in liver (nmol/g tissue) | 6.86±0.86 | 8.87±1.20b | 7.27±0.57a | 6.60±0.87a | 7.21±0.44a |
MT content in stomach (mg/g protein) | 1.080±0.066 | 1.875±0.285c | 1.925±0.7ce | 1.813±0.448ce | 1.493±0.188c |
MT content in liver (mg/g protein) | 9.955±1.358 | 28.325±7.117 | 54.165±19.224ce | 56.63±15.218ce | 12.575±6.106c |
n = 6 in each group.
P<0.05 vs stress group,
P<0.01 vs control group,
P<0.05 vs control,
P<0.05 vs stress group, respectively.